AKT1 and breast cancer: INPP4B shRNA knockdown in breast cancer cell lines increased cell proliferation, motility, anchorage-independent cell growth, xenograft tumour growth and disrupted mammary acini morphology in an AKT-dependent manner (Table 2) [121,129].